Joint Modelling Approaches to Survival Analysis via Likelihood-Based Boosting Techniques

Table 4

Structure of the dataset with primary outcomes for the joint analysis in the three columns on the left.

				Drug	Gender	AZT	prevOI	ID
10.67	16.97	0	0	ddC	Male	Intolerance	AIDS	1
8.43	16.97	0	6	ddC	Male	Intolerance	AIDS	1
9.43	16.97	0	12	ddC	Male	Intolerance	AIDS	1
6.32	19.00	0	0	ddI	Male	Intolerance	noAIDS	2
8.12	19.00	0	6	ddI	Male	Intolerance	noAIDS	2
4.58	19.00	0	12	ddI	Male	Intolerance	noAIDS	2
5.00	19.00	0	18	ddI	Male	Intolerance	noAIDS	2
3.46	18.53	0	0	ddI	Female	Intolerance	AIDS	3
3.61	18.53	0	2	ddI	Female	Intolerance	AIDS	3
6.16	18.53	1	6	ddI	Female	Intolerance	AIDS	3
⋮	⋮	⋮	⋮	⋮	⋮	⋮	⋮	⋮